OWC Pharmaceutical Research Corp. (OTCPK:OWCP) announced a private placement of 588,235 units at a price of $0.17 per unit for gross proceeds of $100,000 on January 13, 2017. Each unit consists of one restricted common share and one class H warrant. Each warrant is exercisable at an exercise price of $0.40 for a period of 36 months. The transaction included participation from accredited investors. The securities were issued pursuant to exemption provided under Regulation D and Regulation S.